AGA Medical

AGA Medical was a medical device company founded in 1995 in Plymouth, Minnesota, by Dr. Kurt Amplatz and Frank Gougeon. The company specialized in designing, manufacturing, and marketing innovative cardiovascular implants aimed at treating congenital heart defects in both pediatric and adult patients. AGA Medical is particularly known for the Amplatzer Septal Occluder, a device that allows for the closure of heart defects through a minimally invasive procedure, eliminating the need for open-heart surgery. The product line included a variety of cardiovascular implants such as occluders and plugs, specifically designed to address structural heart defects like atrial septal defects (ASD) and patent foramen ovale (PFO). These devices were recognized for their unique design and effectiveness, significantly improving treatment outcomes and recovery times for patients. AGA Medical primarily served hospitals, cardiologists, and pediatric cardiology centers, focusing on interventional cardiology and minimally invasive cardiac procedures. In 2010, AGA Medical was acquired by St. Jude Medical for $1.3 billion, and it became part of Abbott Laboratories in 2017. The company left a strong legacy in the field of pediatric and adult cardiology through its innovative technology and contributions to the medical device industry.

• Employees 350
• Founded 1995
• Annual Revenue $198700000